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ABSTRACT  19 
We investigated the underlying molecular mechanisms by which post-exercise cold-water 20 
immersion (CWI) may alter key markers of mitochondrial biogenesis following both a single 21 
session and six weeks of sprint interval training (SIT).  Nineteen males performed a single 22 
SIT session, followed by one of two 15-min recovery conditions: cold-water immersion 23 
(COLD; 10°C) or a passive room-temperature control (CON; 23°C). Sixteen of these 24 
participants also completed six weeks SIT, each session followed immediately by their 25 
designated recovery condition. Four muscle biopsies were obtained in total, three during the 26 
single SIT session (pre-exercise, post-recovery, and 3 h post-recovery), and one 48h after the 27 
last SIT session. Following a single SIT session, phosphorylated (p-) AMPK, p-p38 MAPK, 28 
p-p53, and PGC1α mRNA were all increased (P < 0.05). Post-exercise CWI had no effect on 29 
these responses. Consistent with the lack of a response following a single session, regular 30 
post-exercise CWI had no effect on PGC-1α or p53 protein content. Six weeks of SIT 31 
increased peak aerobic power, V̇O2peak, maximal uncoupled respiration (complexes I and II), 32 
and 2-km time-trial performance (P < 0.05). However, regular CWI had no effect on changes 33 
in these markers, consistent with the lack of response in the markers of mitochondrial 34 
biogenesis. While these observations suggest CWI is not detrimental to endurance 35 
adaptations following six weeks of SIT, they question whether post-exercise CWI is an 36 
effective strategy to promote mitochondrial biogenesis and improvements in endurance 37 
performance.  38 
INTRODUCTION 39 
Despite the popularity of post-exercise cold-water immersion (CWI) in athletic training 40 
regimes, few studies have investigated its effect on the adaptive response to endurance-41 
related training. Notably, there have been no studies investigating the use of CWI in 42 
conjunction with sprint-interval training (SIT). Some research involving lower intensity 43 
exercise indicates CWI may stimulate a number of cellular responses related to skeletal 44 
muscle mitochondrial biogenesis following a single exercise session in humans (1, 33, 34). 45 
Furthermore, improvements in skeletal muscle recovery following CWI (67) may allow 46 
athletes to train with a higher quality and/or load in subsequent sessions, potentially 47 
providing a greater stimulus for adaptation (29). However, these benefits may be 48 
counteracted by the attenuation of molecular responses related to vascular remodeling and 49 
heat-shock protein induction (74), resulting in long-term detrimental effects on skeletal 50 
muscle adaptations and endurance performance. Given the contrasting findings reported to 51 
date, clarification of the effects of CWI on both molecular responses to a single exercise 52 
session and adaptations to exercise training are warranted. 53 
In humans, post-exercise exposure to cold has been reported to augment increases in 54 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) mRNA (34, 55 
61, 62) - an important regulator of skeletal muscle mitochondrial biogenesis (41). Increases in 56 
PGC-1α mRNA following post-exercise muscle cooling have been attributed to both 57 
shivering and non-shivering thermogenesis (34, 61, 62). For example, 1 h of exercise 58 
followed by 3 h of recovery in a cold (7°C) environment induced significantly greater 59 
increases in PGC-1α mRNA in human skeletal muscle, compared with a room-temperature 60 
(20°C) control condition (62). The increase in PGC-1α mRNA reported by Slivka et al. (62) 61 
was attributed in part to contraction-induced increases in calcium (Ca2+) and adenosine 62 
monophosphate (AMP) as a result of shivering. Apart from producing heat via repetitive 63 
muscle contraction and subsequent energy expenditure, shivering may also serve to activate 64 
PGC-1α via the upstream kinases calcium/calmodulin-dependent protein kinase and AMP-65 
activated protein kinase (AMPK) (62). Consistent with work in adipose tissue and muscle 66 
cells (53, 72), PGC-1α mRNA has also been reported to increase in human skeletal muscle 67 
following post-exercise cold-water immersion (CWI) via non-shivering thermogenesis (34) - 68 
a process by which heat is produced from shivering-independent mechanisms such as 69 
mitochondrial uncoupling and substrate cycling (70). This cold-induced increase in PGC-1α 70 
mRNA may be related to β-adrenergic stimulation and nitric oxide synthesis (34), and/or 71 
altered calcium handling and subsequent p38 MAPK/AMPK phosphorylation (33). These 72 
studies suggest that cold application may be a novel method to promote exercise-induced 73 
mitochondrial biogenesis in humans, but further research is required to identify additional 74 
underlying mechanisms.  75 
p53 is another key transcription factor involved in the regulation of exercise-induced 76 
mitochondrial biogenesis (58). As shown in a number of different cell and tissue types, p53 77 
plays an important role in regulating mitochondrial content, oxidative capacity, and exercise 78 
performance (44, 50, 56, 58, 59). Apart from its well-defined role in response to genotoxic 79 
stress and associated DNA damage, research has also implicated p53 activation in response to 80 
everyday stressors (e.g., metabolic stress from exercise) (9). p53 activation has also been 81 
reported following cold stress (28 °C) in cultured cells (43), implicating the cold stress 82 
imposed by post-exercise CWI as a potential stimulus to augment exercise-induced increases 83 
in p53 activation. Once activated, p53 transcriptionally regulates genes associated with 84 
energy metabolism and mitochondrial biogenesis (9, 28), including mitochondrial 85 
transcription factor (Tfam) (59), apoptosis inducing factor (AIF) (64), mitofusin-2 (Mfn2) 86 
(68), dynamin-related protein 1 (Drp1) (39), and synthesis of cytochrome c oxidase 2 (SCO2) 87 
(44). Should cold stress increase p53 activity, this would provide an alternate explanation by 88 
which post-exercise CWI might augment exercise-induced mitochondrial biogenesis.  89 
Two studies have investigated the effects of regular post-exercise CWI on skeletal muscle 90 
adaptations to high-intensity endurance training (1, 33). Consistent with a greater increase in 91 
PGC-1α mRNA after a single session of high-intensity running followed by CWI (34), 92 
regular post-exercise CWI (administered during four weeks of training) was reported to 93 
increase the abundance of a number of proteins associated with mitochondrial biogenesis 94 
(e.g., PGC-1α, subunits of respiratory complexes I and III, and β-HAD) (33). In contrast, a 95 
recent study by Aguiar et al (1) reported that regular CWI administered during 4 weeks of 96 
high-intensity cycle training had no additional effect on training-induced increases in PGC-1α 97 
protein content. However, although one study has observed a significant increase in p53 98 
protein content following four weeks of sprint interval training (SIT) (28), no study has 99 
investigated the effects of regular CWI on the content of this transcription factor. Another 100 
major gap in the literature is that no study has investigated the effect of regular post-exercise 101 
CWI on markers of mitochondrial function (e.g., mass-specific mitochondrial respiration) and 102 
content (e.g., citrate synthase activity).  103 
We investigated, for the first time in the same experiment, the effects of post-exercise CWI 104 
on mitochondrial content and function and some of the underlying molecular mechanisms. 105 
The present investigation was divided into two studies (a single exercise trial with biopsies 106 
and a training intervention). The aim of the biopsy trial was to investigate the response of the 107 
p53 pathway, and other molecular mechanisms, following a single exposure to post-exercise 108 
CWI. The aim of the training intervention was to investigate the effects of regular post-109 
exercise CWI on the protein content of these transcription factors, as well as mitochondrial 110 
content and function. It was hypothesized that CWI administered after SIT would augment 111 
these molecular responses (independent of shivering, i.e., non-shivering thermogenesis), 112 
consistent with the up-regulation of PGC-1α gene expression and protein accumulation 113 
reported when CWI was administered following high-intensity running (33, 34). It was also 114 
hypothesized that a CWI-induced increase in p53 signaling and protein accumulation would 115 
provide a basis for improved aerobic phenotype adaptations, including mitochondrial 116 
respiration, maximal oxygen consumption (V̇O2peak), and endurance exercise performance. 117 
Considering the widespread use and acceptance by athletes of CWI as a recovery modality 118 
following training, the overall aim of this research was to provide mechanistic insights into 119 
its effects on skeletal muscle adaptations to training.  120 
METHODS 121 
Participants 122 
Recruited participants were recreationally-active, performing some form of aerobic exercise 123 
(e.g. running, cycling) for ~30-60 min per day, ~2-3 days per week. Participants were not 124 
involved in a structured training regime or specifically trained to compete in any one sport. 125 
Informed consent was obtained prior to participation, and all participants were screened for 126 
cardiovascular risk factors associated with exercise. All procedures were approved by the 127 
Institution’s Human Research Ethics Committee. The study followed a two-group parallel 128 
design, in which participants were assigned to one of two recovery conditions in a 129 
randomized, counter-balanced fashion. These conditions were a passive control (CON) or 130 
cold-water immersion (COLD).  131 
Briefly, the experimental protocol consisted of i) familiarization and baseline testing; ii) a 132 
single exercise trial with biopsies, iii) a six-week SIT intervention, and iv) post-training 133 
testing. Nineteen healthy males began the study and completed the biopsy trial (CON, n=10; 134 
COLD, n=9). Of these nineteen participants, sixteen completed the six-week training 135 
intervention and all post-training measures (CON, n=8; COLD, n=8). Participant 136 
characteristics are detailed in Table 1. 137 
Table 1: Participant characteristics 138 
 CON Group COLD Group 
Biopsy Trial   
Age (years) 25 ± 6 23 ± 4 
Mass (kg) 81.3 ± 13.2 77.4 ± 7.7 
Height (cm) 181.7 ± 8.9 179.2 ± 11.4 
Body mass index 24.6 ± 3.4 24.2 ± 2.7 
Training Intervention   
Age (years) 26 ± 7 24 ± 4 
Mass (kg) 82.9 ± 14.3 77.1 ± 8.1 
Height (cm) 181.8 ± 10.0 179.8 ± 12.1 
Body mass index 25.1 ± 3.7 24.0 ± 2.8 
 139 
Familiarization  140 
Prior to baseline testing, participants made several familiarization visits to the laboratory to 141 
become accustomed with the equipment and testing procedures. These sessions included a 142 
graded exercise test (GXT), a 2-km cycling time trial (TT2), and 20-km cycling time trial 143 
(TT20), all performed on isolated days, and separated by at least 24 h. Participants also 144 
completed a familiarization session of the SIT, and their assigned recovery condition.  145 
Baseline Testing 146 
Participants completed baseline trials of the TT2, TT20, and GXT protocols. All baseline trials 147 
were separated by at least 24 h, and performed in the morning (0700-1000) following an 148 
overnight fast. Participants were asked to refrain from exercise and alcohol consumption for 149 
24 h prior to each trial.   150 
Biopsy Trial 151 
Following an overnight fast and abstinence from exercise and alcohol for the preceding 152 
twenty-four hours, participants reported to the laboratory in the morning (0730) for the 153 
biopsy trial. Upon arrival, the lateral aspect of the right thigh (dominant leg for all 154 
participants) was anaesthetized (1% Xylocaine). Three separate incisions were made through 155 
the skin and underlying fascia, corresponding to the three muscle biopsies taken during the 156 
experiment (pre-exercise, post-recovery and 3 h post-recovery). The incisions were made 157 
approximately one-third of the distance from the knee to the hip, parallel to the long axis of 158 
the leg and spaced 1-2 cm apart. Using a 5-mm Bergström needle modified with suction (21), 159 
muscle biopsies were taken from the belly of the vastus lateralis. The first biopsy was taken 160 
at rest, immediately before the SIT session (Pre). Participants then performed the single SIT 161 
session and their designated recovery condition. Exactly two minutes post-recovery, a second 162 
muscle biopsy was taken (Post-Rec). Participants remained in the laboratory, fasted and at 163 
rest, until a third biopsy was taken 3 h post-recovery (3 h). The Post-Rec and 3 h biopsy 164 
incision sites were covered with sterile gauze and a water-proof dressing (Tegaderm, 3M, 165 
North Ryde, Australia) during exercise and recovery. Following each biopsy, the 166 
corresponding incision site was closed with a suture. Samples were blotted on filter paper to 167 
remove blood and immediately snap-frozen in liquid nitrogen, then stored at -80°C until 168 
subsequent analyses. Prior to freezing, a small piece (~15-20 mg) of fresh muscle was 169 
sectioned from the pre-training biopsy for immediate analysis (within 5 min) of 170 
mitochondrial respiration. Participants were allowed to consume water ad libitum during the 171 
trial. This session doubled as the first training session for the sixteen participants who 172 
subsequently completed the SIT intervention.   173 
Sprint Interval Training Intervention 174 
Sixteen participants completed three training sessions per week for six weeks. On an 175 
electronically-braked cycle ergometer (Velotron, Racer-Mate, Seattle, WA), participants first 176 
completed a 5-min warm-up at 75 W. This was immediately followed by 4-6 x 30-s ‘all-out’ 177 
efforts at a constant resistance corresponding to 7.5-9.5% of body mass, separated by 4 min 178 
of rest. To ensure a progressive training stimulus during the six-week training period, 179 
participants performed 4 repetitions in weeks 1-2, five in weeks 3-4, and six in weeks 5-6. 180 
Resistance ranged from 7.5-9.5% of body mass, so that the fatigue-induced reduction in 181 
power during the 30-s bout was at least 20 W.s-1. To eliminate individual variance with self-182 
administered ‘speeding up’ of the flywheel, participants began each effort from a rolling start 183 
corresponding to 120 rpm. During each effort, participants were given extensive verbal 184 
encouragement and asked to remain seated in the saddle. This protocol has been shown to 185 
rapidly upregulate the oxidative phenotype, comparable to long-duration continuous 186 
endurance exercise (22, 23). Participants were asked to refrain from all other types of 187 
exercise during the training intervention.  188 
Post-Training Testing 189 
A resting muscle biopsy was taken ~48-72 h after the final training session from the same leg 190 
used during the baseline testing (Post). Participants also completed post-training trials for the 191 
TT2, TT20, and GXT protocols. The timing and nature of post-training testing was identical to 192 
baseline testing.   193 
Exercise Performance Tests 194 
Time Trials 195 
On the same electronically-braked cycle ergometer used during training, participants were 196 
instructed to complete TT2 and TT20 self-paced time-trials as quickly as possible. The only 197 
feedback given to participants during the trials was an update of distance covered: the half-198 
way mark (1 km) during the TT2 and every 2 km during the TT20. Participants were allowed 199 
to control the gear ratio throughout the entire time trial, corresponding to three gearings on 200 
the chain-ring (28, 39 and 52) and ten on the rear sprocket (23, 21, 19, and 17-11). Heart rate 201 
(RS800sd, Polar Electro Oy, Finland), exercise duration and average power were recorded 202 
during the trial.  203 
Graded Exercise Test 204 
Participants performed a discontinuous GXT on an electronically-braked cycle ergometer 205 
(Lode, Groningen, The Netherlands) to determine their lactate threshold (LT) and peak 206 
aerobic power (Wpeak). An intermittent protocol was used, with 4-min exercise stages and 30-207 
s rest stages. Following a 5-min steady state warm-up at 75 W, the workload was increased 208 
by 30 W every 4.5 min until the participant reached volitional fatigue. The starting workload 209 
varied between 60-120 W, ascertained from the familiarization GXT, capping the number of 210 
stages to a maximum of ten.  Participants were instructed to maintain a pedaling cadence of 211 
70 rpm and wore a heart rate monitor during the test. The test was stopped when pedaling 212 
cadence dropped below 60 rpm. Blood samples for the GXT were taken from a venous 213 
catheter (Optiva IV Catheter 20G x 1.75", Smiths Medical, USA) inserted into an antecubital 214 
vein 10 min prior to the first blood draw. The LT was determined as the workload at which 215 
venous blood lactate increased 1 mM above baseline (10), and was calculated using Lactate-E 216 
version 2.0 software (47). Wpeak was calculated as previously reported (30): 217 
Wpeak = Wfinal + (
𝑡𝑡
240
·30); where Wfinal was the power output of the last completed stage and t 218 
was the time in seconds of any final uncompleted stage. 219 
Peak Oxygen Uptake  220 
After volitional fatigue in the GXT, participants performed 5 min of passive rest before 221 
performing a V̇O2peak test. This comprised of a steady-state cycle to fatigue at a supra-222 
maximal power output corresponding to 105% of Wpeak, previously reported to elicit V̇O2peak 223 
values no different to that determined during a ramp incremental test performed 5 min 224 
previously (55). Participants were asked to maintain a pedaling cadence of 90-100 rpm until 225 
volitional fatigue, with the test terminated when cadence dropped below 80 rpm. Expired 226 
gases were analyzed every 15 s using a custom-made metabolic cart. The gas analyzers (S-227 
3lA/II and CD-3A analyzers, Ametek, PA, USA) were calibrated using known gas 228 
concentrations prior to each test (20.93% O2, 0.04% CO2 and 16.10% O2, 4.17% CO2; BOC 229 
Gases, Australia). V̇O2peak was defined as the average of the two highest consecutive values 230 
reached during the test. 231 
Recovery Interventions 232 
Exactly five minutes after completing each training session, participants performed their 233 
assigned recovery intervention for 15 min. Seated (with legs fully extended), participants 234 
were immersed in water up to their umbilicus (COLD: 10°C), or rested on a laboratory bed 235 
(CON: 23°C). The COLD condition was performed in an inflatable bath (iBody, iCool Sport, 236 
Australia), and water temperature was maintained with a cooling/heating unit (Dual Temp 237 
Unit, iCool Sport, Australia) as previously described (12). We have previously reported the 238 
application of this CWI protocol after the same exercise protocol to reduce intramuscular (4 239 
cm) temperature from 37.1°C to 33.6°C following an identical exercise session (12). Due to 240 
the nature of water immersion per se, a hydrostatic pressure of ~20-30 mmHg (71) would 241 
have been exerted on the COLD participants during  recovery. There were no observed or 242 
reported signs of shivering during CWI for all participants, at all time points. 243 
Muscle Analyses - Biopsy Trial (Pre vs Post-Rec vs 3h) 244 
Preparation of Whole-Muscle Lysates for Western Blotting 245 
A 10-15 mg piece of frozen muscle was added to ice-cold homogenizing buffer (37.5 µL.mg-246 
1 tissue; 20 mM Tris, 137 mM NaCl, 1% Triton-X, 10% Glycerol, 2.7 mM KCl, 1 mM MgCl, 247 
1 mM EDTA, 1 µg.mL-1 aprotinin, 1 µg.mL-1 leupeptin, 1 mM benzamedine, 1 mM Na3VO4, 248 
1 mM NaF, 5 mM sodium pyrophosphate, 1 mM dithiothreitol, 1 mM phenylmethanesulfonyl 249 
fluoride – adjusted to pH 7.4), and homogenized on ice using a motorized pestle. The whole 250 
muscle lysate was used for Western blotting without centrifugation (46). Protein 251 
concentration of the lysate was determined using a commercially-available colorimetric assay 252 
(Bio-Rad, Hercules, CA), using bovine serum albumin (BSA) as the standard. All samples 253 
were diluted with distilled water to a standard concentration (1.5 µg. µL-1), and further 254 
diluted with 2 x Laemmli buffer (125 mmol.L-1 Tris-HCl pH 6.8, 4% SDS, 20% glycerol, 255 
0.015% bromophenol blue, 10% β-mercaptoethanol). The resultant lysate was split equally 256 
into two parts: one unboiled and the other boiled at 95°C for 5 min. Both lysate fractions 257 
were subsequently stored at -80°C for future analyses.  258 
Western Blot Analysis 259 
Optimization gels were run for all antibodies to determine optimal conditions for western blot 260 
detection (i.e. loading volume and boiled vs un-boiled lysate). Muscle lysates were loaded 261 
equally (15 µg) and separated on 10% self-cast SDS-PAGE gels by means of electrophoresis, 262 
at 100 V for 1.5-2 h (Bio-Rad, Mississauga, ON, Canada). Unboiled muscle lysate was used 263 
for all proteins except p-p53Ser15, in which samples were re-boiled at 95°C for 3 min prior to 264 
loading. Once resolved, gels were transferred wet onto polyvinylidene fluoride (PVDF) 265 
membranes in transfer buffer (25mM Tris, 192mM glycine, 20% methanol, 0.01% SDS) at 266 
100 V for 90 min. Membranes were then blocked with 5% skim milk in Tris-buffered saline 267 
(TBST: 150 mM NaCl, 20 mM Tris, 0.1% Tween-20, pH 7.4) for 1 h at room temperature. 268 
Following 5 x 5 min washes in TBST, the membranes were incubated overnight (4°C with 269 
gentle agitation) with monoclonal primary antibodies (Cell Signaling Technology, MA, USA; 270 
CST), diluted 1:1000 in 5% BSA or skim milk, against phosphorylated-AMPKThr172 (Product 271 
Number 2531 CST), p38 mitogen-activated protein kinase (p38 MAPKThr180/Tyr182; 9211 272 
CST), and p53Ser15 (9284 CST). The following morning, membranes were again washed 5 x 273 
5-min in TBST, and incubated in the appropriate species-specific horseradish peroxidase-274 
conjugated secondary antibodies (Goat anti-rabbit IgG, NEF812001EA; Perkin Elmer, 275 
Waltham, MA, USA) at room temperature for 90 min, diluted 1:10000 (1:5000 for p-AMPK 276 
only) in 5% skim milk and TBST. After a further 5 x 5-min washes in TBST, membranes 277 
were exposed to a chemiluminescent liquid (ClarityTM Western ECL Substrate, Bio-Rad, 278 
Hercules, CA, USA) and visualized using a VersaDoc 4000 MP imaging system (Bio-Rad, 279 
Hercules, CA, USA). Band densities were determined using Image Lab 5.1 software (Bio-280 
Rad, Hercules, CA, USA). Membranes were then stained with 0.1% Coomassie R-350 281 
(PhastGelTM Blue R, GE Healthcare) as previously described (69), thereby providing a 282 
loading and transfer control. Comparative samples for each participant were loaded into the 283 
same gel, and one lane for each gel was reserved for an internal standard to account for inter-284 
gel variability. Raw blot density was normalized to the internal standard and coomassie stain 285 
prior to analysis.   286 
Total RNA Isolation 287 
Approximately 20-30 mg of frozen muscle was added to 1 g of zirconia/silica beads (1.0 mm: 288 
Daintree Scientific, Tasmania, Australia) and 800 µL of commercially available TRIzol 289 
reagent (Invitrogen, Carlsbad, CA, USA), and homogenized using an electronic homogenizer 290 
(FastPrep FP120 Homogenizer, Thermo Savant). Samples were centrifuged at 13000 rpm for 291 
15 min (4°C) to pellet cell debris. The upper homogenate was then removed and pipetted into 292 
250 µL chloroform (Sigma Aldrich, St Louis, MO), and again centrifuged at 13000 rpm for 293 
15 min (4°C). Without disturbing the interphase, the top phase was pipetted into a fresh 294 
Eppendorf containing 400 µL of 2-isopropanol alcohol (Sigma-Aldrich, St Louis, MO, USA) 295 
and 10 µL of 5 M NaCl, and stored at -20°C overnight to allow for RNA precipitation. The 296 
following morning the sample was centrifuged at 13000 rpm for 20 min (4°C), following 297 
which the majority of the isopropanol was aspirated. The remaining RNA pellet was washed 298 
once with 75% ethanol made with diethylpyrocarbonate-treated (DEPC) H2O (Invitrogen Life 299 
Sciences), and centrifuged at 9000 rpm for 8 min (4°C). Ethanol was aspirated off, and the 300 
pellet was re-suspended in 5 uL of heated DEPC-treated H2O. RNA concentration was 301 
quantified spectrophotometrically (NanoDrop 2000, Thermo Fisher Scientific, Wilmington, 302 
DE, USA) at 230 (A230), 260 (A260) and 280 (A280) nm, with an average yield of 1251.9 ± 303 
466.7 ng.µL-1, an A260/280 ratio of 1.78 ± 0.11, and an A260/230 ratio of 1.14 ± 0.38. RNA was 304 
stored at -80°C until further analysis.  305 
Real-Time RT-PCR 306 
One microgram of RNA was reverse transcribed into cDNA using a thermal cycler (S1000TM 307 
Thermal Cycler, Bio-Rad, Hercules, CA, USA) and a commercially available kit (iScript™ 308 
cDNA Synthesis Kit, Bio-Rad, Melbourne, Australia) with random hexamers and oligo dTs, 309 
according to the manufacturer’s instructions. All samples and RT negative controls were run 310 
together to prevent technical variation. ‘Real-time’ PCR reactions (total volume 10 µL) were 311 
performed with iTaqTM Universal SYBR® Green Supermix (Bio-Rad, Hercules, CA, USA) as 312 
the fluorescent agent. The following cycling patterns were used: initial denaturation at 95°C 313 
for 3 min, 40 cycles of 95°C for 15 s and 60°C for 60 s (Mastercycler® RealPlex2, 314 
Eppendorf, Hamburg, Germany). Forward and reverse primers for target genes were designed 315 
using sequences obtained from GenBank (Table 2). All samples were run in duplicate with 316 
negative controls, using an automated pipetting system (epMotion 5070, Eppendorf, 317 
Hamburg, Germany). To account for the efficiency of RT and initial RNA concentration, the 318 
mRNA abundance of the housekeeping genes glyceraldehyde 3-phosphate dehydrogenase 319 
(GAPDH), TATA-binding protein (TBP) and β2 microglobulin (β2M) were quantified, and 320 
target genes were normalized to the geometric mean of all three. Relative changes in mRNA 321 
abundance were calculated as described previously (31). 322 
Table 2: Primer sequences used for real-time PCR 323 
Gene (protein) Forward Primer Reverse Primer 
GAPDH 
(glyceraldehyde 
3-phosphate 
dehydrogenase) 
AAAGCCTGCCGGTGACTAAC CGCCCAATACGACCAAATCAGA 
TBP (TATA-
box binding 
protein) 
CAGTGACCCAGCAGCATCACT AGGCCAAGCCCTGAGCGTAA 
β2M (β2-
microglobin) 
TGCTGTCTCCATGTTTGATGTATCT TCTCTGCTCCCCACCTCTAAGT 
PPARGC1A 
(PGC-1α) GGCAGAAGGCAATTGAAGAG TCAAAACGGTCCCTCAGTTC 
NRF1 (Nuclear 
respiratory 
factor 1) 
CTACTCGTGTGGGACAGCAA AGCAGACTCCAGGTCTTCCA 
NFE2L2 
(NRF2) AAGTGACAAGATGGGCTGCT TGGACCACTGTATGGGATCA 
TFAM 
(Mitochondrial 
transcription 
factor A) 
CCGAGGTGGTTTTCATCTGT GCATCTGGGTTCTGAGCTTT 
TP53 (P53) GTTCCGAGAGCTGAATGAGG TTATGGCGGGAGGTAGACTG 
MFN2 
(Mitofusin-2) 
CCCCCTTGTCTTTATGCTGATGTT TTTTGGGAGAGGTGTTGCTTATTTC 
AIFM1 (AIF) GATTGCAACAGGAGGTACTCCAAGA GATTTGACTTCCCGTGAAATCTTCTC 
SCO2 
(synthesis of 
cytochrome c 
oxidase) 
CTTCACTCACTGCCCTGACA CGGTCAGACCCAACAGCTT 
DNM1L 
(DRP1) CACCCGGAGACCTCTCATTC CCCCATTCTTCTGCTTCCAC 
CIRBP (CIRP) CCCGACTCAGTGGCCG AGCGACTGCTCATTGGTGTC 
RBM3 (Putative 
RNA-binding 
protein 3) 
GGACGTTCTCGCTACGTACTC ACATGGCAGTTCAAGTCCTGG 
UCP3 
(Uncoupling 
protein 3) 
CCACAGCCTTCTACAAGGGATTTA ACGAACATCACCACGTTCCA 
PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; NRF2, 324 
Nuclear respiratory factor 2; AIF; Apoptosis-inducing factor;  DRP1, dynamin-related protein 325 
1; CIRP, Cold-inducible RNA-binding protein.   326 
Muscle Analyses - SIT Intervention (Pre vs Post) 327 
Preparation of Permeabilized Skeletal Muscle Fibers.  328 
A small section (~15-20 mg) of fresh muscle was analyzed for mitochondrial respiration pre- 329 
and post-training. The sample was immediately placed into a cold biopsy preservation 330 
solution (BIOPS; 2.77 mM CaK2EGTA, 7.23 mM K2EGTA, 5.77 mM Na2ATP, 6.56 mM 331 
MgCl2, 20 mM taurine, 50 mM K+-4-morpholinoethanesulfonic acid (MES), 15 mM 332 
Na2phosphocreatine, 20 mM imidazole and 0.5 mM dithiothreitol (DTT) - pH 7.1 (52)), and 333 
subsequently mechanically separated using forceps. Fibers were permeabilized by gentle 334 
agitation (30 min at 4°C) in a solution of BIOPS containing 50 μg/mL of saponin, and 335 
washed (3 x 7 min at 4°C) by gentle agitation in the respiration medium solution (MiR05; 336 
0.5mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 337 
mM HEPES, 110 mM sucrose and 1% bovine serum albumin (BSA) - pH 7.1 at 37°C (52)). 338 
This method selectively permeabilizes the cellular membrane leaving the mitochondria intact, 339 
allowing for “in-situ” measurements of mitochondrial respiration. 340 
High-Resolution Respirometry 341 
After washing, fibers were weighed (~3-4 mg wet weight) and assayed in duplicate in a high-342 
resolution respirometer (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria), with each 343 
chamber containing 2 mL of MiR05. Oxygen concentration (nmol/mL) and oxygen flux 344 
(pmol·s-1·mg-1) were measured at 37°C and recorded using DatLab software (Version 5, 345 
Oroboros Instruments), corrected to instrumental background oxygen flux. Each chamber was 346 
continually re-oxygenated by direct syringe injection of O2 into the chamber to allow for 347 
maintenance of O2 concentration (275-450 nmol/mL) to avoid a potential oxygen diffusion 348 
limitation.  349 
Mitochondrial respiration measurements were taking using a substrate-uncoupler-inhibitor 350 
titration (SUIT) protocol. Firstly, the substrates pyruvate (final chamber concentration; 2 351 
mM) and malate (5 mM) were added in the absence of adenylates for measurement of leak 352 
respiration (L) with electron entry through Complex I (CI) (CIL). Next, adenosine 353 
diphosphate (ADP) was added (5 mM) for measurement of maximal oxidative 354 
phosphorylation (OXPHOS) capacity (P) with electron input through CI (CIP), followed by 355 
addition of succinate (10 mM) for measurement of P with electron supply through CI and 356 
Complex II (CII) combined (CI&IIP). This state provides convergent electron input to the Q-357 
junction through CI (NADH provided by malate and pyruvate) and CII (FADH2 provided by 358 
succinate) and supports maximal mitochondrial respiration by reconstruction of the citric acid 359 
cycle function. Cytochrome c (10 μM) was next added to assess outer mitochondrial 360 
membrane integrity – increases in O2 flux > 10% after cytochrome c addition indicated 361 
compromised membrane integrity, in which data was excluded. A series of stepwise carbonyl 362 
cyanide 4-(trifluoromethoxy) phenylhydrazone titrations (FCCP, 0.75-1.5 μM) were 363 
performed, to determine maximal uncoupled respiration and electron transport system 364 
capacity (E), with convergent electron input through CI and CII (CI&IIE). Rotenone (0.5 365 
μM), an inhibitor of CI, was added next to determine E with electron input through CII alone 366 
(CIIE). Antimycin A (2.5 μM), an inhibitor of Complex III (CIII), was then added to measure 367 
residual oxygen consumption capacity (ROX); this was used to correct all respiration values. 368 
Mitochondrial respiration measures represent an average of the technical duplicates (i.e. 369 
average of both chambers), expressed in both absolute oxygen flux (mass-specific 370 
mitochondrial respiration) and corrected to citrate synthase activity (mitochondria-specific 371 
respiration). Complete mitochondrial respiration data sets were available for 12 participants 372 
(CON, n=6; COLD n=6) as a result of malfunctions with the respirometer and/or poor muscle 373 
sample quality. 374 
Preparation of Whole-Muscle Lysates and Western Blot Analyses 375 
Preparation of the whole-muscle lysate was performed in the same manner as that for the 376 
biopsy trial. The whole muscle lysate was used for both enzyme activity assays and Western 377 
blotting, without centrifugation. Western blots were performed with unboiled muscle lysate 378 
for all proteins except p53, in which samples were re-boiled at 95°C for 3 min prior to 379 
loading. Membranes were incubated overnight with monoclonal primary antibodies (1:500-380 
5000 in 5% skim milk) against p53 (2527 CST), and PGC-1α (ST1202 Merck Millipore, 381 
Billerica, MA, USA). Secondary antibodies (Goat anti-mouse IgG (NEF822001EA Perkin 382 
Elmer, Waltham, MA, USA) for PGC-1α) diluted 1:7000-30000 in 5% skim milk and TBST. 383 
All other western blot procedures were identical to those detailed in the biopsy trial 384 
methodology.  385 
Citrate Synthase Activity  386 
The maximal enzyme activity of citrate synthase (CS) was determined using the lysate 387 
prepared for western blot analyses, and analyzed on a spectrophotometer (Bio-Rad, Hercules, 388 
CA). Each well contained a 50-fold dilution of lysate (2mg/mL), 3mM Acetyl CoA, 1mM 389 
dystrobrevin beta (DTNB), and 10 mM oxaloacetate (OAA), made to volume (250 µL) with 390 
Tris buffer (100 mM). Reactions were analyzed over a 3 min period at 30°C, with absorbance 391 
(412 nM) recorded every 15 s. Samples were analyzed in triplicate, with enzyme activity 392 
expressed as moles per hour per kilogram of protein (µM.h-1.kg-1 protein).  393 
Statistical Analyses 394 
Data are reported in the text as means and standard deviation (mean ± SD), unless otherwise 395 
stated. Comparisons between conditions were analyzed using a two-way general linear model 396 
(ANOVA) with repeated measures for time, where the within-subject factor was time (Biopsy 397 
Trial - Pre vs Post-Rec vs 3 h; Training Intervention – Pre vs Post) and the between-subject 398 
factor was condition (CON vs COLD). Where significant time or interaction (time x 399 
condition) effects were found, multiple pairwise comparisons were evaluated by Welch’s t 400 
test, corrected to the false discovery rate method (19). The level of significance for all data 401 
was set at P < 0.05. The above analyses were performed using IBM SPSS Statistics V20 402 
(IBM Corporation, USA). To compliment the statistical hypothesis testing, effect sizes (ES) 403 
were calculated to assess the magnitude of observed effects. Cohen’s conventions for effect 404 
size (Cohen’s d ± 90% confidence intervals) were used for interpretation, where ES = 0.2, 405 
0.5, and 0.8 are considered as small, medium and large, respectively. Raw western blot 406 
densitometry data (corrected to internal standard and coomassie stain) and changes in mRNA 407 
abundance (RT-PCR data) were used for statistical analyses. For graphical purposes, baseline 408 
western blot and RT-PCR values were normalized to 1.0, such that Post-Rec and 3 h values 409 
correspond to fold change from Pre values. 410 
RESULTS 411 
SIT Session and Training 412 
Both groups performed similar volumes of total work during the single session of SIT, 67.5 ± 413 
11.8 kJ (CON) and 65.3 ± 10.1 kJ (COLD) (P > 0.05). Similarly, both groups performed 414 
similar volumes of training over the six weeks, 1518.7 ± 180.9 kJ and 1487.0 ± 242.4 kJ for 415 
CON and COLD respectively (P > 0.05). There was 98% adherence to the training program, 416 
with 2 participants in the CON group and 3 participants in COLD group missing one training 417 
session each due to illness. No differences were observed for the characteristics listed in 418 
Table 1 (P > 0.05), demonstrating effective randomization of participants into the two 419 
conditions.   420 
Muscle Analyses –Biopsy Trial  421 
Western Blots 422 
Significant effects of time were observed for the phosphorylation (p-) of p38 MAPKThr180/182 423 
(P = 0.029) and p-AMPKThr172 (P = 0.002). Specifically, p-p38 MAPKThr180/182 was elevated 424 
post-recovery (P = 0.029, ES = 1.00 ± 0.70), but returned to basal levels by 3 h post-recovery 425 
(P = 0.487). There was a similar increase in p-AMPKThr172 post-recovery (P = 0.002, ES = 426 
0.78 ± 0.51), which remained significantly elevated 3 h post-recovery (P = 0.006, ES = 0.77 427 
± 0.40). There were no interaction effects for either p-p38 MAPKThr180/182 (P = 0.901) or p-428 
AMPKThr172 (P = 0.472) (Fig. 1). 429 
There was a significant effect of time for p-p53Ser15 (P = 0.007). Specifically, p-p53Ser15 was 430 
elevated post-recovery (P = 0.011, ES 1.54 ± 1.15) and remained significantly elevated 3 h 431 
post-recovery (P = 0.011, ES 2.39 ± 1.70). There was no interaction effect for p-p53Ser15 (P = 432 
0.142). However, there were large effects for the change in p-p53Ser15 content between 433 
conditions (COLD vs CON) at both post-recovery (2.7-fold vs 1.5-fold; ES = 1.68 ± 1.79) 434 
and 3 h post-recovery (3.7-fold vs 1.7-fold; ES = 2.69 ± 2.78) (Fig. 1).   435 
mRNA 436 
There were no effects of time for the housekeeping genes GAPDH (P = 0.668), TBP (P = 437 
0.748), and β2M (P = 0.193). A significant effect of time (P < 0.001) was observed for PGC-438 
1α mRNA, with post-hoc analysis revealing it was significantly elevated 3 h post-recovery (P 439 
< 0.001, ES = 8.49 ± 1.77). However, no interaction effect was observed for PGC-1α mRNA 440 
(P = 0.738). There were no time or interaction effects for the mRNA content of nuclear 441 
respiratory factor-1 (NRF-1; P = 0.212 and 0.812, respectively), nuclear respiratory factor-2 442 
(NRF-2; P = 0.492 and 0.645, respectively) or mitochondrial transcription factor (TFAM; P = 443 
0.318 and 0.467, respectively) (Fig. 2A). 444 
There were no main effects of time for the mRNA content of P53 (P = 0.062), or the p53 445 
downstream targets mitofusin-2 (MFN2; P = 0.335), dynamin-related protein 1 (DRP1; P = 446 
0.994), synthesis of cytochrome c oxidase (SCO2; P = 0.274) or apoptosis inducing factor 447 
(AIF; P = 0.517). An interaction effect was demonstrated for MFN2 mRNA (P = 0.033), but 448 
when corrected to the false discovery rate the critical significance level was not achieved. 449 
There were no interaction effects for P53 (P = 0.707), DRP1 (P = 0.279), SCO2 (P = 0.214) 450 
or AIF (P = 0.078) mRNA. At the 3 h post-recovery time-point, there were moderate effects 451 
for the change in mRNA content of MFN2 (1.2-fold vs 0.8-fold; ES = 0.53 ± 0.40), AIF (1.3-452 
fold vs 0.9-fold; ES = 0.63 ± 0.65) and SCO2 (1.3-fold vs no change; ES = 0.70 ± 0.80) 453 
between conditions (Fig. 2B).  454 
No time or interaction effects were observed for the mRNA content of cold-inducible RNA-455 
binding protein (CIRP; P = 0.475 and 0.168, respectively), RNA-binding motif protein 3 456 
(RBM3; P = 0.151 and 0.262, respectively), or uncoupling protein 3 (UCP3; P = 0.245 and 457 
0.490, respectively). However, there was a moderate effect (ES = 0.50 ± 0.57) for the change 458 
in RBM3 mRNA content between conditions 3 h post-recovery (1.3-fold vs no change) (Fig. 459 
2C). 460 
Muscle Analyses – Training Intervention  461 
Western Blots 462 
There were no time or interaction effects for PGC-1α (P = 0.437 and 0.751, respectively) or 463 
p53 (P = 0.304 and 0.446, respectively) content (Fig. 3).   464 
CS Activity and Mitochondrial Respiration 465 
There were no time (10.0 ± 23.8% increase; P = 0.232) or interaction (P = 0.656) effects for 466 
changes in maximal citrate synthase activity as a result of training (Fig. 4).  467 
There were no interaction effects for all mass-specific respiration measures (P > 0.05). 468 
However, there was a significant time effect for CI&IIE (P = 0.013, ES = 0.82 ±0.48), which 469 
increased 21.6 ± 24.8% following six weeks of SIT. Similar mean percentage changes were 470 
observed for the change in CIP (23.8 ± 47.5%; P = 0.181, ES = 0.37 ± 0.49), CI&IIP (13.4 ± 471 
19.8%; P = 0.172, ES = 0.43 ± 0.35) and CIIE (30.6 ± 47.5%; P = 0.546, ES = 0.61 ± 0.53) as 472 
a result of training, but these were not significant due to the considerable individual 473 
variability observed (Fig. 5A).  474 
When normalized to CS activity (mitochondrial-specific respiration), there were no 475 
interaction effects for all measures (P > 0.05). There were no time effects for CIL (P = 0.648), 476 
CIP (P = 0.453) or CI&CIIP (P = 0.656), and small effects (with no effect of time) for the 477 
change in CI&IIE (11.4 ± 24.1%; P = 0.121, ES = 0.33 ± 0.47) and CIIE (21.8 ± 49.7%; P = 478 
0.775, ES = 0.31 ± 0.58) as a result of training (Fig. 5B). 479 
Performance Measures 480 
GXT and VO2peak 481 
Peak power output during the GXT increased by 5.8 ± 5.7 % and 6.1 ± 5.6% in the CON and 482 
COLD groups, respectively (time effect; P = 0.001, ES = 0.31 ± 0.12). Similarly, V̇O2peak 483 
increased significantly as a result of training (main effect of time; P = 0.002, ES = 0.61 ± 484 
0.28), with a 9.6 ± 6.7% increase in the CON group and a 7.6 ± 11.0% increase in the COLD 485 
group. There were no main interaction effects for peak power output (P = 0.979) or V̇O2peak 486 
(P = 0.633) (Fig. 6).  487 
As a result of training, the lactate threshold increased by 162.1 ± 26.7 W to 171.3 ± 36.6 W 488 
for the CON group, and from 155.8 ± 54.8 W to 160.2 ± 59.8 W for the COLD group, with 489 
no main effect of time (P = 0.074) or interaction (P = 0.494).  490 
Time Trials 491 
The time required to finish the TT2 decreased after training by 3.3 ± 4.5% and 2.4 ± 3.1% in 492 
the CON and COLD groups, respectively (time effect; P = 0.010, ES = 0.36 ± 0.21). TT2 493 
mean power correspondingly increased from 261.3 ± 45.0 to 283.5 ± 46.1 W for the CON 494 
group, and from 248.1 ± 66.4 to 263.7 ± 59.2 W for the COLD group (time effect; P = 0.023, 495 
ES = 0.34 ± 0.21). There were no effects of time for TT20 duration (P = 0.224) or mean 496 
power (P = 0.208). Furthermore, there were no interaction effects for TT2 duration (P = 497 
0.699) and mean power (P = 0.666), or TT20 duration (P = 0.889) and mean power (P = 498 
0.703) (Fig. 7). 499 
DISCUSSION: 500 
The main finding of this study was that, contrary to expectations, CWI administered after 501 
sprint-interval exercise had limited effects on exercise-induced mitochondrial biogenesis, 502 
changes in mitochondrial content or function, and measures of endurance exercise 503 
performance. A novel finding of this study was that p53 phosphorylation is increased 504 
following a single session of SIT; however, this response did not translate into training-505 
induced increases in the content of this protein after six weeks of SIT. In contrast to previous 506 
reports of greater increases in PGC-1α mRNA following a single exposure to post-exercise 507 
CWI (34), and greater increases in PGC-1α protein content following regular post-exercise 508 
CWI (33), we observed no differences between conditions in the present study. Six weeks of 509 
SIT significantly increased peak aerobic power, V̇O2peak, maximal uncoupled respiration 510 
(through complexes I and II), and 2-km time-trial performance. However, regular CWI 511 
performed after each training session had no effect on changes in these parameters, consistent 512 
with the lack of an effect of CWI on markers of mitochondrial biogenesis following a single 513 
exercise session. While these observations suggest CWI is not detrimental to endurance 514 
adaptations in response to six weeks of SIT, they question whether CWI following SIT is an 515 
effective strategy to promote mitochondrial biogenesis and improvements in endurance 516 
performance.  517 
Consistent with previous work following high-intensity interval and continuous running (7), 518 
this study provides the observation that p53Ser15 phosphorylation is increased in human 519 
skeletal muscle following a single session of SIT (4 x 30-s all-out cycling efforts) (Fig. 1). 520 
Additionally, we observed that this response is unaltered by CWI. As shown in a number of 521 
different cell and tissue types, p53 plays an important role in regulating mitochondrial content 522 
and oxidative capacity (5). In contrast to the response to other non-genotoxic stresses, such as 523 
fluctuations in oxygen or carbohydrate availability (8, 9), the cold stress imposed by post-524 
exercise CWI had no significant effect on p53 phosphorylation. Given the paucity of research 525 
investigating the acute effects of exercise on the p53 pathway, it is possible that the 3 h post-526 
recovery time point may not have captured the maximal increase in the phosphorylation of 527 
this protein. Nonetheless, the large difference in p53-phosphorylation between conditions 3 h 528 
post-recovery (increase of 3.7-fold for COLD versus 1.7-fold for CON) suggests further 529 
research is warranted to investigate the effects of CWI on the p53 pathway. To further test the 530 
hypothesis that CWI may augment exercise-induced p53 phosphorylation, and consequently 531 
stability (18), a number of p53-target genes were also investigated (Fig. 2B). Two proteins 532 
central to mitochondrial remodeling are the fusion protein Mfn2, and the fission protein Drp-533 
1, both of which are activated by p53 (39, 68). Mfn2 is a mitochondrial GTPase that plays an 534 
important role in mitochondrial fusion, therefore contributing to the maintenance of the 535 
mitochondrial network (4). In contrast to the increase in MFN2 mRNA following a single 536 
bout of sub-maximal intensity continuous cycling (1 h at 60% Wmax) (36, 62), there was no 537 
change in both conditions in the present study. Similarly, there was no change in DRP1 538 
mRNA in both conditions in the present study, consistent with previous research 539 
demonstrating unaltered protein content following two to four weeks of high-intensity 540 
interval training (HIT) (27, 28, 51). Other downstream targets of p53, AIF and SCO2 mRNA, 541 
were unaltered in the CON condition in the present study, consistent with the few published 542 
studies available (42, 57). We add that this response was not influenced by post-exercise 543 
CWI.  544 
Post-exercise CWI also had no additional effect on the exercise-induced increases in AMPK 545 
and p38 MAPK phosphorylation, which has previously been reported following a single 546 
session of high-intensity cycling (24, 40). The prolonged increase in AMPK phosphorylation 547 
(up to 3 h post-recovery) observed in the current study was most likely due to glucose 548 
deprivation following an extended fast (~12 h by the 3 h post-recovery biopsy) and the 549 
completion of an intense exercise session (15). Contrary to expectations, CWI did not 550 
augment p38 MAPK phosphorylation, despite hypothermic stress being a well-accepted 551 
upstream activator (26). This can possibly be attributed, in part, to the already large exercise-552 
induced increase in the level of p38 MAPK phosphorylation observed (~250-300% compared 553 
with previous reports of an ~140% increase (24)); this may have meant there was no 554 
augmented response to the additional stress of CWI. Alternatively, the 3 h post-recovery 555 
biopsy may not have adequately captured the time course of changes in the AMPK and p38 556 
MAPK signaling pathways following post-exercise CWI. However, consistent with links 557 
between activation of p38 MAPK and AMPK and downstream p53Ser15 phosphorylation (7), 558 
CWI had no additional effect on the phosphorylation of these kinases following a single 559 
session of SIT.  560 
Both energy- (AMPK) and stress-dependent (p38 MAPK) kinase signaling (2, 35) has been 561 
implicated in PGC-1α activation following HIT (41), a response that was supported in the 562 
present study. Similar to previous research (40), we observed an increase in PGC-1α mRNA 563 
following a single session of SIT (Fig. 2A). However, post-exercise CWI had no additional 564 
influence on the increase in PGC-1α mRNA, consistent with the lack of an influence on its 565 
upstream activators p38 MAPK and AMPK. This contrasts with previous reports that post-566 
exercise CWI (8-10°C for 10-15 min) (34, 37) and cold ambient exposure (4°C for 3-4 h) (61, 567 
62) augment PGC-1α mRNA levels, compared with a passive room temperature control. 568 
However, certain methodological differences may explain the inconsistencies between these 569 
studies and the current study. For example, it is unlikely that 15 min of CWI would have 570 
elicited a shivering response and/or a reduction in core temperature of the same magnitude as 571 
the 3-4 h cold exposure used in the two studies from Slivka (61, 62). In regards to the studies 572 
by Ihsan (34) and Joo (37), these inconsistencies could be explained by the mode and 573 
intensity of exercise (and thus the metabolic stimulus) performed prior to CWI, the 574 
temperature and duration of CWI,  differences in nutritional status of participants between 575 
studies, and/or differences in RT-PCR methodology. This may be further compounded by the 576 
fact that our participants were fasted, which may similarly enhance AMPK and p38 MAPK 577 
phosphorylation and subsequent PGC-1α activation (6).  578 
To provide further insight into the effects of regular post-exercise CWI on potential cellular 579 
mechanisms modulating adaptation to SIT, the protein content of PGC-1α following the 580 
training period was also measured. No difference was observed between the CON and COLD 581 
conditions, consistent with the similar changes in PGC-1α mRNA observed after a single 582 
session of SIT with and without CWI. This is consistent with the non-significant ~1.2-fold 583 
increase in PGC-1α protein content observed when CWI was used regularly after a high-584 
intensity running training period (33). While PGC-1α protein has been reported to increase 585 
(~1.5 fold) following cold-air exposure (4°C for as little as 4 d) in rodent skeletal muscle (13, 586 
49), these increases were likely the result of shivering thermogenesis (49) and extended cold-587 
exposure (i.e., 4°C, 24 h/d for 4-5 wk) (13) - which were not characteristic of the CWI 588 
protocol used in the current study. The present data therefore suggest that CWI has no effect 589 
on SIT-induced PGC-1α protein accumulation in humans, but continued work in this area 590 
(including potential CWI-induced alterations in PGC-1α post-translational modification and 591 
nuclear content) will help clarify the above-mentioned inconsistencies. 592 
A novel aspect of this study was to directly assess for the first time the effect of regular post-593 
exercise CWI on training-induced improvements in mitochondrial respiration in 594 
permeabilized muscle fibers. Despite a smaller than expected increase for the CON group in 595 
the current study, there was a ~13% increase in maximal mass-specific respiration (CI&IIP) 596 
when participants were pooled, comparable to previous reports in participants of a similar 597 
training status (28). The smaller improvements reported in the current study, as compared 598 
with Granata et al. (28), may be explained by the number of ‘all-out’ bouts performed, 599 
differences in age and training status, and the large variability typically associated with 600 
respiration measures. However, consistent with the similar response for markers of 601 
mitochondrial adaptation (i.e., PGC-1α and p53 protein content), regular CWI had no 602 
influence on training-induced changes in mass-specific mitochondrial respiration.  603 
To determine if the increases in mass-specific respiration were qualitative or quantitative, 604 
mass-specific respiration was corrected to CS activity (to calculate mitochondria-specific 605 
respiration). Located exclusively in the mitochondria (65), CS is an enzyme commonly used 606 
in exercise training studies as a biomarker of mitochondrial content (11, 38). Similar to the 607 
observations for mass-specific respiration, and consistent with similar training-induced 608 
increases PGC-1α and p53 protein content, CWI had no effect on changes in mitochondria-609 
specific respiration. As such, and contrary to our hypothesis, these data suggest CWI does not 610 
serve to augment increases in mitochondrial respiration in response to SIT. Further research 611 
is warranted to investigate whether CWI can augment training-induced mitochondrial 612 
adaptations, especially when combined with a larger training volume that will induce more 613 
robust increases in CS activity/mitochondrial content (11). 614 
Another novel aspect of this study was to investigate changes in the mRNA content of the 615 
cold-shock proteins (CSPs) CIRP and RBM3, and UCP3, following post-exercise CWI (Fig. 616 
2C). It is well accepted that transcription and translation is suppressed in response to cold 617 
stress, accompanied by a reduction in RNA degradation and alternate splicing of pre-mRNA 618 
(3, 63, 73). Despite their integral roles in mRNA stabilization and global protein synthesis 619 
under cold stress (20, 63), CIRP and RBM3 mRNA were unchanged following post-exercise 620 
CWI. Previously reported to reduce intramuscular temperature by ~3°C (12), the CWI 621 
protocol used in the current study induced a small (~30%) yet non-significant increase in 622 
RBM3 mRNA 3 h after CWI. However, it is possible that a more drastic reduction in muscle 623 
temperature (~5°C) is needed for a significant increase in RBM3 mRNA (20). Similarly, 624 
CIRP mRNA was unchanged 3 h following post-exercise CWI. The expression of CIRP 625 
mRNA however, has been reported to peak between 6 and 24 h following mild (32°C) cold 626 
exposure in mouse fibroblasts (48), which may explain the lack of response 3 h after post-627 
exercise CWI. UCP3, an uncoupling protein expressed predominantly in skeletal muscle (60), 628 
has recently been implicated as an integral mediator of mammalian thermogenesis during 629 
cold exposure (54). In the current study, UCP3 mRNA was unchanged 3 h following post-630 
exercise CWI (Fig. 2C), consistent with the response reported by Slivka et al (62). It is 631 
possible that the CWI protocol used in the current study did not provide an adequate cold-632 
stress to elicit an increase in UCP3 mRNA. Another potential explanation for the subtle 633 
effect of post-exercise CWI on CIRP, RBM3 and UCP3 mRNA is the exercise stimuli itself, 634 
as a more pronounced increase in gene expression may have occurred without a preceding 635 
exercise stimulus.  636 
An important applied aspect of this research was to determine if regular CWI had any effect 637 
on exercise performance. Although it has previously been suggested that CWI may be 638 
detrimental to training-induced changes in exercise performance (74), this study provides 639 
evidence that regular CWI following sprint-interval cycling has no detrimental (or 640 
advantageous) influence on physiological and performance markers of endurance adaptations, 641 
including time-trial performance, the lactate threshold, V̇O2peak, and peak aerobic power. 642 
These findings support the absence of a significant difference between conditions for the 643 
measured markers of mitochondrial biogenesis (i.e., p53, PGC-1α, CS activity etc.). It is 644 
important to note that V̇O2peak, peak aerobic power, and time-trial performance all increased 645 
following SIT, without concurrent increases in molecular markers (i.e. PGC-1α protein 646 
content, mitochondrial respiration, CS activity). Although these molecular markers are have 647 
been associated with improved V̇O2max (41), many other factors could have contributed to the 648 
increase in performance markers as a result of SIT, including alterations in hemodynamic 649 
(16, 17) and cardiorespiratory (14, 45, 66) factors, as well as improvements in substrate 650 
transport and utilisation (14, 17, 25). Nonetheless, this performance data supports the only 651 
other published study investigating the effects of regular CWI following cycling training, 652 
whereby CWI performed four times per week during three weeks of cycling training did not 653 
impair performance adaptations in competitive cyclists (29). Given that the participants in the 654 
current study were considerably less trained in comparison, this suggests that training status 655 
does not influence these effects. Finally, this data, along with that of Halson et al. (29), does 656 
not support concerns of CWI being detrimental to adaptations to endurance training (32, 74).   657 
Perspective and Significance 658 
The most important finding from the present study was that regular CWI following sprint-659 
interval cycling has no advantageous (or detrimental) influence on markers of endurance-660 
related training adaptations and cycling performance. This study provides evidence that p53 661 
phosphorylation is increased following a single session of SIT; however, this did not translate 662 
into a greater increase in its content following six weeks of SIT, suggesting that this signaling 663 
response does not accurately predict training responses. Contrary to our hypothesis, a number 664 
of molecular markers associated with skeletal muscle metabolic adaptations and 665 
mitochondrial biogenesis were not altered by post-exercise CWI when compared with a 666 
passive control. For example, CWI had no additional influence on the exercise-induced 667 
increases in p38 MAPK or AMPK activation, consistent with the lack of response of their 668 
downstream targets PGC-1α and p53. Given the inconsistencies in molecular responses 669 
between the current study and those reported with CWI following high-intensity interval 670 
exercise [12, 15], future research incorporating larger sample sizes and/or additional biopsy 671 
time points may help clarify the effects of CWI on the signaling pathways and training 672 
adaptations associated with SIT. These findings refute previous suggestions that exercise-673 
induced training benefits may be counteracted by possible CWI-induced long-term 674 
detrimental effects on muscular adaptation, but also question whether post-exercise CWI 675 
following sprint-interval cycling is an effective strategy to promote mitochondrial biogenesis 676 
and improvements in endurance performance. 677 
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FIGURE CAPTIONS: 893 
Figure 1: Phosphorylation of p38 mitogen-activated protein kinase (p38 MAPKThr180/Tyr182) 894 
(A),adenosine monophosphate-activated protein kinase (AMPKThr172) (B), and p53Ser15 (C) 895 
from muscle sampled pre-exercise (Pre), post-recovery (Post-Rec), and 3 h post recovery (3 896 
h) for control (CON; n=10) and cold-water immersion (COLD; n=9) conditions. Thr, 897 
threonine; Tyr, tyrosine; Ser, serine. *Significant difference compared with pre (P < 0.05). ‡ 898 
Large effect (ES > 0.8) compared with CON. Data are presented as mean ± S.D. 899 
Representative western blots are displayed above each graph. The vertical dividing line 900 
represents non-adjacent lanes from separate gels. All samples were derived at the same time 901 
and processed in parallel.  902 
Figure 2: Gene expression from muscle sampled 3 h post-recovery for control (CON; n=10) 903 
and cold-water immersion (COLD; n=9) conditions for PGC-1α and downstream targets (A), 904 
P53 and downstream targets (B), and cold-shock/uncoupling proteins (C). NRF-1/2, Nuclear 905 
respiratory factors 1/2; TFAM, Mitochondrial transcription factor; PGC-1α, Peroxisome 906 
proliferator-activated receptor gamma coactivator 1-α; DRP1, dynamin-related protein 1; 907 
MFN2, mitofusion 2; AIF, apoptosis-inducing factor; SCO2, synthesis of cytochrome c 908 
oxidase 2; CIRP, cold-inducible RNA-binding protein; RBM3, putative RNA-binding protein 909 
3; UCP3, uncoupling protein 3. Corrected to glyceraldehyde 3-phosphate dehydrogenase 910 
(GAPDH), TATA-binding protein (TBP) and β2 microglobulin (β2M) housekeeping genes. 911 
*Significant difference compared with pre (P < 0.05). † Moderate effect (ES = 0.5-0.8) 912 
compared with CON. Data are presented as mean ± S.D. 913 
Figure 3: Total PGC-1α and p53 protein content before (Pre) and after (Post) six weeks of 914 
sprint interval training (SIT) for the control (CON; n=8) and cold-water immersion (COLD; 915 
n=8) conditions. Data are presented as fold change (mean ± S.D.) from pre values. 916 
Representative western blots are displayed above each graph. All samples were derived at the 917 
same time and processed in parallel. 918 
Figure 4: Maximal activity of the mitochondrial enzyme citrate synthase (CS) before (Pre) 919 
and after (Post) six weeks of sprint interval training (SIT) for the control (CON; n=8) and 920 
cold-water immersion (COLD; n=8) conditions. Data are presented as mean ± S.D. 921 
Figure 5: Mitochondrial respiration measurements at different coupling control states. A: 922 
mass-specific mitochondrial respiration, and B: mitochondria-specific respiration (mass-923 
specific respiration normalized to citrate synthase activity). Respiration was measured in 924 
permeabilized muscle fibers (vastus lateralis) obtained before and after six weeks of sprint 925 
interval training (SIT) for control (CON, n=6) and cold-water immersion (COLD, n=6) 926 
conditions. Data are presented as percent change (mean ± S.E.M.) from pre values. CIL: Leak 927 
respiration state (L) in the absence of adenylates and limitation of flux by electron input 928 
through Complex I (CI); CIP; maximal oxidative phosphorylation state (P) with saturating 929 
levels of ADP and limitation of flux by electron input through CI; CI&IIP: P with saturating 930 
levels of ADP and limitation of flux by convergent electron input through CI and Complex II 931 
(CII); CI&IIE: maximal electron transport system capacity (E) with saturating levels of ADP 932 
and limitation of flux by convergent electron input through CI and CII; CIIE: E with 933 
saturating levels of ADP and limitation of flux by electron input through CII. * Significant 934 
difference compared with pre-training (P < 0.05). † Moderate effect compared with pre-935 
training. ^ Small effect compared with pre-training.  936 
Figure 6: Peak power output (W) achieved during the graded exercise test (GXT), and peak 937 
oxygen uptake (V̇O2peak; mL.kg-1.min-1) achieved during the steady-state cycle to fatigue 938 
bout, before (Pre) and after (Post) six weeks of sprint interval training (SIT) for the control 939 
(CON; n=8) and cold-water immersion (COLD; n=8) conditions. * Significant effect of 940 
training (p < 0.05). Data are presented as mean ± S.D. 941 
Figure 7: 2-km (TT2) and 20-km (TT20) cycling time-trial performance before (Pre) and after 942 
(Post) six weeks of sprint interval training (SIT) for the control (CON; n=8) and cold-water 943 
immersion (COLD; n=8) conditions. * Significant effect of training (p < 0.05). Data are 944 
presented as mean ± S.D. 945 
